Stablix
PrivateLast Round
Series A
Jun 3, 2021
Total Funding Raised
$63M
Company Overview
Stablix is a biotechnology company that develops a drug discovery platform focused on targeted protein stabilization to treat rare diseases, cancer, and immunological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stablix Comparables
Compare Stablix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vicinitas Therapeutics | 89% | |
| Entact Bio | 87% | |
| Atlas Molecular Pharma | 79% | |
Stablix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 3, 2021 |
Key People
Founding team and executive leadership
Stablix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates (NEA) | Series A |
| Cormorant Asset Management | Series A |
| Versant Ventures | Series A |
| Cormorant Asset Management | Series A |
| Euclidean Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2021
$63M round led by Versant Ventures
Stablix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stablix's valuation, stock price, and market status.